Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages

Journal of Neuroimmunology

Volumn 89, Issue 1-2, 1998, Pages 206-212

  Xin, Zhicheng ^a   Sriram, Subramaniam ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

IL 12; Macrophages; NO; VIP

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; NITRIC OXIDE; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GASTROINTESTINAL TRACT; IMMUNE RESPONSE; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; NERVOUS SYSTEM; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; CYCLIC AMP; FEMALE; FORSKOLIN; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED STRAINS; MITOGENS; NEUROPEPTIDES; NITRIC OXIDE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SUPERANTIGENS; THIOGLYCOLATES; TUMOR NECROSIS FACTOR-ALPHA; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032516760     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00140-4     Document Type: Article

References (43)

1. Alonso A.et al. Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. J. Immunol. 154:1995;6475-6483.
2. Blalock E.J. Shared ligands and receptors as a molecular mechanisms for communication between the immune and neuroendocrine systems. Ann. New York Acad. Sci. 741:1994;292-298.
3. Brosnan C., Raine C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:1996;243-257.
4. Bulut V.et al. Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem. Biophys. Res. Commun. 195:1993;1134-1138.
5. Chao C.C.et al. Glia, cytokine and neurotoxicity. Crit. Rev. Neurobiol. 9:1995;189-205.
6. Finch R.J.et al. High affinity receptors for VIP on human myeloma cells. J. Immunol. 142:1989;1977-1987.
7. Gaillard T.et al. Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe-Seyler. 373:1992;897-900.
8. Gehrman et al., 1995.
9. Gomariz R.P.et al. Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus. Brain Behav. Immunol. 4:1990;151-157.
10. Gomariz R.P.et al. Occurrence of vasoactive intestinal peptide inn lymphoid organs from rat and mouse. Ann. New York Acad. Sci. 650:1992;13-21.
11. Gomariz R.P.et al. VIP gene expression in rat thymus and spleen. Brain Behav. Immunol. 7:1993;271-278.
12. Heufler C.et al. IL-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunnol. 26:1996;659-668.
13. Imai T.et al. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93:1994;543-549.
14. Inagaki N.et al. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. 91:1994;2679-2683.
15. Ishihara T.et al. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal peptide. Neuron. 8:1992;811-819.
16. Koch F.et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and regulation by IL-4 and IL-10. J. Exp. Med. 184:1996;741-746.
17. Koide et al., 1993.
18. Ma X.et al. The interleukin 12 p40 gene promoter is primed by interferon r in monocytic cells. J. Exp. Med. 183:1996;147-157.
19. Manetti R.et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1) specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177:1993;1199-1204.
20. Marotta P.et al. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107:1992;640-641.
21. Miyata et al., 1989.
22. Mullet D.et al. An increase in intracellular cyclic AMP modulates nitric oxide production in IFN gamma-treated macrophages. J. Immunol. 158:1997;897-904.
23. O'Dorisio M.S.et al. Identification of high affinity receptors for VIP on human lymphocytes of the B lineage. J. Immunol. 142:1989;3533-3543.
24. Ottaway C.et al. Vasoactive intestinal peptide-containing nerves in Peyer's patches. Brain Behav. Immunol. 1:1987;148-154.
25. Ottaway C.A.et al. High affinity specific binding of VIP to human circulating T cells, B cells and large granular lymphocytes. J. Neuroimmunol. 29:1990;149-159.
26. Poliak S.et al. The neuropeptides corticotrophin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immunol. 158:1997;5751-5756.
27. Pozo D.et al. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes. Biochim. Biophys. Acta. 1312:1996;249-254.
28. Reichlin S. Neuroendocrine-immune interactions. New Engl. J. Med. 329:1993;1246-1250.
29. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 169:1970;1217-1218.
30. Said S.A., Mutt V. Isolation from porcine-intestinal wall of a vasoactive octasapeptide related to secretin and glucagon. Eur. J. Biochem. 28:1972;190-194.
31. Segal B.M.et al. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol. 158:1997;5087-5090.
32. Shintani F.et al. Role of interleukin-1 in stress responses. Mol. Neurobiol. 10:1995;47-71.
33. Sim K.B.et al. Vasoactive intestinal polypeptide in mouse and rat brain. Brain Res. 186:1980;165-167.
34. Skeen M.J.et al. Regulation of murine macrophage IL-12 production. J. Immunol. 156:1996;1196-1206.
35. Stanisz A.M.et al. Differential effects of VIP, SP and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patchs, mesenteris lymph and spleen. J. Immunol. 136:1986;151-156.
36. Sternberg et al., 1997.
37. Stoychkov et al., 1979.
38. Sun L., Ganea D. Vasoactive intestinal peptide inhibits interleukin IL-2 and IL-4 production through different molecular mechanism in T cells activated via the T cell receptor/CD3 complex. J. Neuroimmunol. 48:1993;59-70.
39. Tineke C.T.M.et al. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med. 181:1995;775-779.
40. Trinchieri G. Interleukin-12: a cytokine produced by antigen presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 12:1994;4008-4027.
41. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
42. Xin et al., 1994.
43. Xin Z.et al. Vasoactive intestinal peptide inhibits interleukin IL-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol. 54:1995;59-68.